4 Notable Health Tech Funding Announcements in May

Why It Matters

The influx of capital underscores investors’ confidence that AI and data‑centric models will reshape care delivery, cost management, and patient engagement across the U.S. health ecosystem.

Key Takeaways

• Forus secures $160M to expand AI-driven authorization platform
• Garner Health raises $100M, valuation hits $2.74B
• Nourish's $100M Series C backs virtual dietitian network
• Commure obtains $70M to scale AI revenue-cycle tools

Pulse Analysis

The health‑tech sector is entering a new growth phase, driven by deep‑pocket investors betting on artificial intelligence to solve long‑standing inefficiencies. In May alone, four companies—Forus, Garner Health, Nourish, and Commure—collectively raised $430 million, reflecting a broader market trend where capital follows platforms that can automate complex workflows, from insurance authorizations to revenue‑cycle management. This capital surge signals that venture firms see scalable, data‑rich solutions as essential to modernizing a fragmented U.S. healthcare system.

AI’s role is central to each of these deals. Forus leverages machine learning to streamline prior‑authorizations, reducing administrative burdens for providers nationwide. Garner Health’s massive dataset of 60 billion medical records powers algorithms that match employees with high‑performing physicians, aligning employer cost‑containment goals with patient outcomes. Nourish combines virtual dietitian access with an AI health agent to personalize metabolic care, while Commure integrates ambient AI into practice‑management tools, promising faster billing cycles and better resource allocation for hospitals. These technologies illustrate how AI is moving from experimental pilots to core revenue drivers.

The implications for the broader industry are significant. Employers gain more leverage to steer healthcare spending toward value‑based care, providers benefit from reduced paperwork and improved cash flow, and patients receive more coordinated, data‑informed experiences. As funding continues to flow, we can expect accelerated adoption of AI platforms, heightened competition among health‑tech startups, and a push toward integrated solutions that address both clinical and financial dimensions of care. Stakeholders should monitor how these investments translate into measurable cost savings and patient‑outcome improvements over the next 12‑18 months.